Biosergen AS (BIOSGN)

Currency in SEK
0.49
-0.02(-3.95%)
Closed·
BIOSGN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BIOSGN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.490.51
52 wk Range
0.281.14
Key Statistics
Prev. Close
0.51
Open
0.51
Day's Range
0.49-0.51
52 wk Range
0.28-1.14
Volume
83.49K
Average Volume (3m)
313.01K
1-Year Change
-23.44%
Book Value / Share
0.18
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOSGN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Biosergen AS Company Profile

Biosergen AB (publ), a biotech company, develops antifungal products. Its lead product is BSG005, an antifungal drug candidate for the treatment of invasive fungal infections in immunocompromised patients, including AIDS, cancer, and transplant recipients. The company was founded in 2004 and is based in Solna, Sweden.

Compare BIOSGN to Peers and Sector

Metrics to compare
BIOSGN
Peers
Sector
Relationship
P/E Ratio
−6.6x−9.6x−0.5x
PEG Ratio
−0.08−0.200.00
Price/Book
2.7x6.5x2.6x
Price / LTM Sales
-69.1x3.3x
Upside (Analyst Target)
194.1%97.5%43.5%
Fair Value Upside
Unlock8.3%6.9%Unlock

Earnings

Latest Release
May 29, 2025
EPS / Forecast
-0.02 / -0.02
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BIOSGN Income Statement

FAQ

What Stock Exchange Does Biosergen AS Trade On?

Biosergen AS is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Biosergen AS?

The stock symbol for Biosergen AS is "BIOSGN."

What Is the Biosergen AS Market Cap?

As of today, Biosergen AS market cap is 114.12M.

What Is Biosergen AS's Earnings Per Share (TTM)?

The Biosergen AS EPS (TTM) is -0.07.

When Is the Next Biosergen AS Earnings Date?

Biosergen AS will release its next earnings report on 27 Aug 2025.

From a Technical Analysis Perspective, Is BIOSGN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Biosergen AS Stock Split?

Biosergen AS has split 0 times.

How Many Employees Does Biosergen AS Have?

Biosergen AS has 2 employees.

What is the current trading status of Biosergen AS (BIOSGN)?

As of 07 Aug 2025, Biosergen AS (BIOSGN) is trading at a price of 0.49, with a previous close of 0.51. The stock has fluctuated within a day range of 0.49 to 0.51, while its 52-week range spans from 0.28 to 1.14.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.